CHPA Applauds Arizona's Adoption Of HB 2263
Law Implements Real-Time, Stop-Sale Technology
WASHINGTON, May 14, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded Arizona Governor Jan Brewer for signing into law House Bill 2263—anti-meth legislation authored by Representative Heather Carter (R-LD7). Arizona now becomes the 23rd state to adopt real-time, stop-sale technology known as the National Precursor Log Exchange (NPLEx).
The proven system—in a process similar to a credit card transaction—allows retailers to automatically block unlawful pseudoephedrine (PSE) purchases in real-time and at the point of sale. Data collected by NPLEx also provides law enforcement officials with valuable data that helps them build stronger cases and make more arrests. NPLEx is an effective, targeted solution to domestic meth production that protects law-abiding citizens' access to safe and effective cold and allergy medicines containing PSE.
"With the adoption of HB 2263, Arizona lawmakers have taken a significant step in the battle against methamphetamine production and abuse," said Scott M. Melville, president and chief executive officer of CHPA. "It's no coincidence that 23 states around the country have chosen real-time, stop-sale technology to combat meth crime. Based on what we've learned from law enforcement experts and pharmacists who use the system every day, it's clear that the technology is working extremely well across the country. In 2011 alone, the system blocked over 2 million grams from potentially being misused by meth cooks.
"Not only does NPLEx help police officers track down meth manufacturers and distributors, it also ensures that responsible consumers have access to the nonprescription cold and allergy medicines they depend on. Representative Carter and the entire legislature worked hard to find the right solution to a difficult problem facing their state. Thanks to these efforts, law enforcement officials and retailers will now have the upper hand against meth criminals."
SOURCE The Consumer Healthcare Products AssociationBack to top